Genetics and vaccine efficacy: Host genetic variation affecting Marek's disease vaccine efficacy in White Leghorn chickens

Poultry Science

Volumn 89, Issue 10, 2010, Pages 2083-2091

  Chang, S ^a,b,c   Dunn, J R ^a   Heidari, M ^a   Lee, L F ^a   Song, J ^d   Ernst, C W ^c   Ding, Z ^b   Bacon, L D ^a   Zhang, H ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b JILIN UNIVERSITY   (China)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Host genetics; Marek's disease vaccine; Vaccine efficacy

Indexed keywords

GALLUS GALLUS; HERPESVIRIDAE; MELEAGRID HERPESVIRUS 1;

EID: 77958111907     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2010-00740     Document Type: Article

References (55)

1. Bacon, L. D., L. K. Ch'ng, J. Spencer, A. A. Benedict, A. M. Fadly, R. L. Witter, and L. B. Crittenden. 1986. Tests of association of immunoglobulin allotype genes and viral oncogenesis in chickens. Immunogenetics 23:213-220.
2. Bacon, L. D., and R. R. Dietert. 1991. Genetic control of cell-mediated immunity in chickens. Poult. Sci. 70:1187-1199.
3. Bacon, L. D., H. D. Hunt, and H. H. Cheng. 2000. A review of the development of chicken lines to resolve genes determining resistance to diseases. Poult. Sci. 79:1082-1093.
4. Bacon, L. D., J. Motta, H. Cheng, R. Vallejo, and R. Witter. 1996. Use of recombinant congenic chicken strains to define non-HMC genes influencing Marek's disease susceptibility. Pages 63-68 in Current Research on Marek's Disease. R. F. Silva, H. H. Cheng, P. M. Coussens, L. F. Lee, and L. F. Velicer, ed. America Association of Avian Pathologists, Kennett, PA.
5. Bacon, L. D., and R. L. Witter. 1993. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Dis. 37:53-59.
6. Bacon, L. D., and R. L. Witter. 1994a. B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens. Poult. Sci. 73:481-487.
7. Bacon, L. D., and R. L. Witter. 1994b. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Avian Dis. 38:65-71.
8. Bacon, L. D., and R. L. Witter. 1995. Efficacy of Marek's disease vaccines in Mhc heterozygous chickens: Mhc congenic × inbred line F1 matings. J. Hered. 86:269-273.
9. Bacon, L. D., R. L. Witter, L. B. Crittenden, A. Fadly, and J. Motta. 1981. B-haplotype influence on Marek's disease, Rous sarcoma, and lymphoid leukosis virus-induced tumors in chickens. Poult. Sci. 60:1132-1139.
10. Bermudez, A. J., and B. Stewart-Brown. 2008. Disease prevention and diagnosis. Pages 5-42 in Diseases of Poultry. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, ed. Blackwell Publishing, Ames, IA.
11. Burgess, S. C., B. H. Basaran, and T. F. Davison. 2001. Resistance to Marek's disease herpesvirus-induced lymphoma is multiphasic and dependent on host genotype. Vet. Pathol. 38:129-142.
12. Calnek, B. W. 2001. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:25-55.
13. Churchill, A. E., and P. M. Biggs. 1967. Agent of Marek's disease in tissue culture. Nature 215:528-530.
14. Fakhrul Islam, A. F., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. 2008. Kinetics of Marek's disease virus (MDV) infection in broiler chickens. 1: Effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Avian Pathol. 37:225-235.
15. Gavora, J. S., and J. L. Spencer. 1979. Studies on genetic resistance of chickens to Marek's disease-A review. Comp. Immunol. Mi-crobiol. Infect. Dis. 2:359-371.
16. Gavora, J. S., and J. L. Spencer. 1983. Breeding for immune responsiveness and disease resistance. Anim. Blood Groups Biochem. Genet. 14:159-180.
17. Geng, S., and F. J. Hills. 1989. Biometrics in Agricultural Science. Kendall/Hunt Publishing Company, Dubuque, IA.
18. Gimeno, I. M. 2008. Marek's disease vaccines: A solution for today but a worry for tomorrow? Vaccine 26(Suppl. 3):C31-C41.
19. Gimeno, I. M., R. L. Witter, H. D. Hunt, S. M. Reddy, and U. Neumann. 2001. Differential attenuation of the induction by Marek's disease virus of transient paralysis and persistent neurological disease: A model for pathogenesis studies. Avian Pathol. 30:397-409.
20. Gimeno, I. M., R. L. Witter, and W. M. Reed. 1999. Four distinct neurologic syndromes in Marek's disease: Effect of viral strain and pathotype. Avian Dis. 43:721-737.
21. Islam, A. F., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. 2007. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge. Aust. Vet. J. 85:348-355.
22. Jackwood, M. W., L. Hickle, S. Kapil, R. Silva, and R. D. Schults. 2008. Vaccine Development Using Recombinant DNA Technology. Council for Agriculture Science and Technology (CAST), Ames, IA.
23. Lee, L. E., R. L. Witter, S. M. Reddy, P. Wu, N. Yanagida, and S. Yoshida. 2003. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus. Avian Dis. 47:549-558.
24. Lee, L. F., B. Lupiani, R. F. Silva, H. J. Kung, and S. M. Reddy. 2008. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26:1887-1892.
25. Muir, W. M., G. K. Wong, Y. Zhang, J. Wang, M. A. M. Groenen, R. P. M. A. Crooijmans, H.-J. Megens, H. M. Zhang, J. C. McKay, S. McLeod, R. Okimoto, J. E. Fulton, P. Settar, N. P. O'Sullivan, A. Vereijken, A. Jungerius-Rattink, G. A. A. Albers, C. Taylor Lawley, M. E. Delany, and H. H. Cheng. 2008. Review of the initial validation and characterization of a 3K chicken SNP array. World's Poult. Sci. J. 64:219-225.
26. Nazerian, K., and B. R. Burmester. 1968. Electron microscopy of a herpes virus associated with the agent of Marek's disease in cell culture. Cancer Res. 28:2454-2462.
27. Nazerian, K., R. L. Witter, L. F. Lee, and N. Yanagida. 1996. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:368-376.
28. Nunoya, T. 1975. Morphological response of maternal antibody-negative chickens infected with Marek's disease virus (MDV), herpesvirus of turkeys (HVT) and both viruses. Jpn. J. Vet. Res. 23:111-112.
29. Osterrieder, N., J. P. Kamil, D. Schumacher, B. K. Tischer, and S. Trapp. 2006. Marek's disease virus: From miasma to model. Nat. Rev. Microbiol. 4:283-294.
30. Powell, P. C., K. J. Hartley, B. M. Mustill, and M. Rennie. 1983. The occurrence of chicken foetal antigen after infection with Marek's disease virus in three strains of chicken. Oncodev. Biol. Med. 4:261-271.
31. Powell, P. C., N. G. Irving, A. P. Prynne, and M. Rennie. 1986. The differential contribution of B and T lymphocytes to susceptibility to Marek's disease in RPL line-7 chickens. Avian Pathol. 15:597-609.
32. Purchase, H. G., and W. Okazaki. 1971. Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus. Avian Dis. 15:391-397.
33. Rispens, B. H., H. van Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. 1972. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:126-138.
34. Schat, K. A., and B. W. Calnek. 1978. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082.
35. Sharma, J. M., and B. R. Burmester. 1982. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149.
36. Sharma, J. M., and C. K. Graham. 1982. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine. Avian Dis. 26:860-870.
37. Sharma, J. M., R. L. Witter, and B. R. Burmester. 1973. Pathogenesis of Marek's disease in old chickens: Lesion regression as the basis for age-related resistance. Infect. Immun. 8:715-724.
38. Solomon, J. J., R. L. Witter, K. Nazerian, and B. R. Burmester. 1968. Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture. Proc. Soc. Exp. Biol. Med. 127:173-177.
39. Spencer, J. L., A. A. Grunder, A. Robertson, and G. W. Speckmann. 1972. Attenuated Marek's disease herpesvirus: Protection conferred on strains of chickens varying in genetic resistance. Avian Dis. 16:94-107.
40. Stone, H. A. 1975.Use of Highly Inbred Chickens in Research. US-DA-Agricultural Research Service Technical Bulletin No. 1514. USDA, Washington, DC.
41. Vallejo, R. L., L. D. Bacon, H. C. Liu, R. L. Witter, M. A. Groenen, J. Hillel, and H. H. Cheng. 1998. Genetic mapping of quantitative trait loci affecting susceptibility to Marek's disease virus induced tumors in F2 intercross chickens. Genetics 148:349-360.
42. Witter, R. L. 1972. Epidemiology of Marek's disease-A review. Pages 111-122 in Oncogenesis and Herpesvirus. International Agency for Research on Cancer, Lyon, France.
43. Witter, R. L. 1976. Natural mechanisms of controlling lymphotropic herpesvirus infection (Marek's disease) in the chicken. Cancer Res. 36:681-687.
44. Witter, R. L. 1991. Attenuated revertant serotype 1 Marek's disease viruses: Safety and protective efficacy. Avian Dis. 35:877-891.
45. Witter, R. L. 1997. Avian tumor viruses: Persistent and evolving pathogens. Acta Vet. Hung. 45:251-266.
46. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:57-90.
47. Witter, R. L., and B. R. Burmester. 1979. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. Avian Pathol. 8:145-156.
48. Witter, R. L., B. W. Calnek, C. Buscaglia, I. M. Gimeno, and K. A. Schat. 2005. Classification of Marek's disease viruses according to pathotype: Philosophy and methodology. Avian Pathol. 34:75-90.
49. Witter, R. L., and L. F. Lee. 1984. Polyvalent Marek's disease vaccines: Safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol. 13:75-92.
50. Witter, R. L., and L. Offenbecker. 1978. Duration of vaccinal immunity against Marek's disease. Avian Dis. 22:396-408.
51. Witter, R. L., J. M. Sharma, and L. Offenbecker. 1976. Turkey herpesvirus infection in chickens: Induction of lymphoprolifera-tive lesions and characterization of vaccinal immunity against Marek's disease. Avian Dis. 20:676-692.
52. Wu, C., J. Gan, Q. Jin, C. Chen, P. Liang, Y. Wu, X. Liu, L. Ma, and F. Davison. 2009. Revaccination with Marek's disease vaccines induces productive infection and superior immunity. Clin. Vaccine Immunol. 16:184-193.
53. Yonash, N., L. D. Bacon, and E. J. Smith. 2002. Concentration of immunoglobulin G in plasma varies among 6C.7 recombinant congenic strains of chickens. Poult. Sci. 81:1104-1108.
54. Zekarias, B., A. A. Ter Huurne, W. J. Landman, J. M. Rebel, J. M. Pol, and E. Gruys. 2002. Immunological basis of differences in disease resistance in the chicken. Vet. Res. 33:109-125.
55. Zhang, H. M., H. D. Hunt, G. B. Kulkarni, D. E. Palmquist, and L. D. Bacon. 2006. Lymphoid organ size varies among inbred lines 63 and 72 and their thirteen recombinant congenic strains of chickens with the same major histocompatibility complex. Poult. Sci. 85:844-853.